Advertisement
Home Blog Page 2195
No significant difference in outcomes was observed in children and adolescents with fragile X syndrome receiving adaptive versus nonadaptive in-home cognitive training

Computer-Based Training Studied in Children With Fragile X Syndrome

0
Similar improvements seen in groups receiving adaptive, nonadaptive cognitive training program
An elderly California couple who said their cancer was caused by Monsanto's weed killer Roundup was awarded just over $2 billion by a jury in Oakland on Monday.

California Couple Awarded $2 Billion in Roundup Lawsuit

0
Bayer, parent company of Monsanto, maintains glyphosate, main ingredient in Roundup, is safe

American Academy of Neurology, May 4-10

0
The 71st Annual Meeting of the American Academy of Neurology The annual meeting of the American Academy of Neurology was held from May...
A prognostic model can predict the risk for seizures in pregnant women with epilepsy on medication

Tool Predicts Seizure Risk During, After Pregnancy

0
Risk for seizures predicted for pregnant women with epilepsy on medication
Implementation of a beverage excise tax on sugar-sweetened and artificially sweetened beverages in Philadelphia in January 2017 was associated with a reduction in the volume of beverages sold

Taxing Sweetened Beverages Reduces Volume Sold

0
Decrease in beverages sold partially offset by increase in volume of sales in bordering areas
Quitting smoking

Quitting Smoking While Pregnant Tied to Reduced Risk for Preterm Birth

0
Risk reduced even for high-frequency cigarette smokers
Optimal gestational weight gain has limited predictive value for adverse pregnancy outcomes

Gestational Weight Gain Weak Predictor of Adverse Pregnancy Outcomes

0
Meta-analysis identifies estimates of optimal gestational weight gain
The selective Bruton's tyrosine kinase inhibitor evobrutinib at a dose of 75 mg once daily is associated with fewer enhancing lesions during weeks 12 through 24 among patients with relapsing multiple sclerosis

AAN: Oral BTK Inhibitor Superior to Placebo in Multiple Sclerosis

0
Fewer enhancing lesions seen in weeks 12 to 24 for 75 mg evobrutinib once daily versus placebo
A cervical cancer screening strategy that involves cytologic testing every three years from ages 21 to 29 years and then continuing cytologic testing or switching to low-cost high-risk human papillomavirus testing every five years is reasonable

Some Cervical Cancer Screening Strategies More Cost-Effective

0
Most lifetime QALYs seen with cytologic testing every three years, repeated for ASC-US
A single dose of a prophylactic antibiotic is beneficial after operative vaginal birth and reduces the risk for confirmed or suspected maternal infection

Prophylactic Antibiotic Cuts Infection Risk After Operative Vaginal Birth

0
Benefits seen following operative vaginal birth at 36 weeks of gestation or later